MACUS T KUO to Arginine
This is a "connection" page, showing publications MACUS T KUO has written about Arginine.
Connection Strength
2.985
-
Chromatin remodeling system p300-HDAC2-Sin3A is involved in Arginine Starvation-Induced HIF-1a Degradation at the ASS1 promoter for ASS1 Derepression. Sci Rep. 2017 09 07; 7(1):10814.
Score: 0.483
-
Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1a, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation. Oncotarget. 2016 Dec 13; 7(50):82658-82670.
Score: 0.459
-
Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy. Cancer Lett. 2017 03 01; 388:54-63.
Score: 0.458
-
Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents. Oncogene. 2016 Mar 31; 35(13):1632-42.
Score: 0.414
-
Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes. Oncotarget. 2010 Aug; 1(4):246-51.
Score: 0.295
-
Degradation of AMPK-a1 sensitizes BRAF inhibitor-resistant melanoma cells to arginine deprivation. Mol Oncol. 2017 12; 11(12):1806-1825.
Score: 0.122
-
BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma. Oncotarget. 2016 Apr 05; 7(14):17665-80.
Score: 0.109
-
Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin. Oncotarget. 2015 Mar 20; 6(8):6295-309.
Score: 0.102
-
Arginine deprivation in cancer therapy. Curr Opin Clin Nutr Metab Care. 2015 Jan; 18(1):78-82.
Score: 0.100
-
Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction. Mol Cancer Ther. 2013 Nov; 12(11):2581-90.
Score: 0.091
-
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. Br J Cancer. 2012 Apr 24; 106(9):1481-5.
Score: 0.083
-
Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma. Curr Mol Med. 2010 Jun; 10(4):405-12.
Score: 0.073
-
Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1alpha/Sp4. Mol Cancer Ther. 2009 Dec; 8(12):3223-33.
Score: 0.070
-
Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des. 2008; 14(11):1049-57.
Score: 0.062
-
Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma. Int J Mol Sci. 2021 Jul 16; 22(14).
Score: 0.039
-
TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation. Mol Cell Biochem. 2013 Feb; 374(1-2):181-90.
Score: 0.022